Vestura Kit
Product Images NDC 0480-4000

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Vestura (NDC 0480-4000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

A horizontal forest plot displaying hazard ratios and odds ratios from multiple studies, grouped into prospective cohort studies, retrospective cohort studies, case-control studies, and non-fatal idiopathic cases only. Each study is represented with a point estimate and confidence intervals plotted along a logarithmic scale ranging from 0.1 to 10.*

FDA Label Image

2 (Image 2)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (range 1 to 5), COC-Users (range 3 to 9), Pregnant women (range 5 to 20), and Postpartum women (12 weeks only) with a range from 40 to 65. The bars vary in length to show the increasing risk across groups.*

FDA Label Image

3 (Image 3)

A forest plot showing effect estimates with confidence intervals comparing Ever COC vs. Never COC use and Current COC use vs. Never use across multiple studies. The horizontal axis represents effect estimates from -1.50 to 2.00. Individual studies with author names and years are listed on the left, with corresponding odds ratios (OR) and relative risks (RR) with confidence intervals on the right.*

FDA Label Image

New (Image 4)

Chemical structure diagrams of Drospirenone and Ethinyl Estradiol, the active ingredients in Vestura. Both structures are labeled with their respective names and USP designation.*

FDA Label Image

New (Image 5)

A diagram illustrating pregnancy rates per 100 women per year associated with various birth control methods. It features a vertical arrow with 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. Methods linked with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Birth control pills, skin patch, and vaginal ring with hormones are also shown as effective methods. Condoms and diaphragm fall in a middle range, while no sex during fertile days, spermicide, and withdrawal have higher pregnancy rates. No birth control corresponds to the highest pregnancy rate.*

FDA Label Image

4 (Image 6)

The image shows the day label card insert for Vestura, a kit of drospirenone and ethinyl estradiol tablets USP, 3 mg/0.02 mg, by Teva Pharmaceuticals. The card includes markings for days of the week (Sun-Sat) across seven columns and four rows for corresponding weeks. It features storage instructions, the product NDC 0480-4000-28, and Rx only designation on a silver background.*

FDA Label Image

2 (Image 7)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 woman years (WY) across different groups: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnant women (5 to 20), and Postpartum women (12 weeks only) with the highest range from 40 to 65. The x-axis represents the number of women with blood clots, ranging from 0 to 70.*

FDA Label Image

New (Image 8)

Vestura 3 mg/0.02 mg kit packaging label for tablets containing drospirenone and ethinyl estradiol, USP. The label shows a 28-day regimen with 3 tablet dispensers of 28 tablets each. Manufactured by Teva Pharmaceuticals, the box emphasizes the product is prescription only and includes a warning about HIV and other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.